Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2/3 1

Status

Completed 13Terminated 3Recruiting 3Unknown 2Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 20Lymphoid 7Other solid neoplasm 2Gastrointestinal 2Classical hematology 2Plasma cell 1Myeloid 1Gynecologic 1CNS 1Breast 1

Conditions

Neoplasms 1Leukemia, Myeloid, Acute 1Febrile Neutropenia 1Chemotherapy-Induced Febrile Neutropenia 1

Interventions

avatrombopag 4iron isomaltoside 1000 3hetrombopag 3ferric carboxymaltose 3Cytarabine 3eltrombopag 2Rivaroxaban 2Radiotherapy 2Meropenem 2Idarubicin 2Granulocyte Colony-Stimulating Factor 2Etoposide 2Erythropoietin 2Cyclophosphamide 2thymoglobulin 1stinging nettle lectin 1romiplostim 1raltitrexed 1peppermint oil 1pegfilgrastim 1oprelvekin 1fludarabine phosphate 1fludarabine 1ferrous succinate 1ferrous fumarate 1ferric derisomaltose 1epoetin beta 1Vitamin B 12 1Vancomycin 1Valproic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Granulocyte Colony-Stimulating Factor × Classical hematology × Clear all
NCT03823950 2020-03-13

Starting Granulocyte Colony-Stimulating Factor at 1 Day vs 3 Days Following Chemotherapy in Pediatric Cancer Patients

University of Mississippi Medical Center

Phase 4 Unknown
150 enrolled
Classical hematology

Neoplasms, Chemotherapy-Induced Febrile Neutropenia

NCT02427919 2015-04-28

DeGREE

Seoul St. Mary's Hospital

Phase 2/3 Unknown
56 enrolled
Classical hematologyOther hematologic neoplasm

Leukemia, Myeloid, Acute, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡